Djukić-Ćosić D. Toxicological aspect of immunomodulators: friend or foe in increasing the effectiveness of cancer immunotherapy. arhfarm [Internet]. 2022 Oct. 11 [cited 2026 Jul. 12];72(Suppl. 4):S167-S168. Available from: https://asistent.ceon.rs/index.php/arhfarm/article/view/38633